TROPICAMIDE 0.8%w/v IP + PHENYLEPHRINE 5%w/v IP + CHLORBUTOL 0.5%w/v IP

A combination ophthalmic preparation that is used for pupillary mydriasis before fundus examination, cataract, and vitreoretinal surgery. (Sikander A. K. Lodhi, 2021) Makes the pupil of the eye larger and relaxes the muscles in eye. A safe and effective therapeutic option for pupillary mydriasis before cataract surgery. (Sikander A. K. Lodhi, 2021) Dilates the pupil and paralyzes the ciliary body muscle in treatment of ocular disease and diagnosis tests. (Keyvan Shirzadi, 2015) Offers mydriatic effect through direct action on sympathetic nerve receptors located on the pupillary dilator muscle of the iris. (Ji-Hyun Park, 2009) Achieves greater maximum mydriasis than tropicamide or phenylephrine alone. (Jingyi Cheng, 2017) An appropriate choice that is effective and provides adequate dilatation for all ophthalmological clinical situations. (Anupriya Arthur, 2018) A potent and rapid mydriatic drug for almost 40 years, mainly because of its suitable duration of action and minimal side effects. (Anupriya Arthur, 2018) The most common dilating agent in clinical ophthalmological practice (Anupriya Arthur, 2018)